ATE445393T1 - Tablette mit gefärbtem kern - Google Patents

Tablette mit gefärbtem kern

Info

Publication number
ATE445393T1
ATE445393T1 AT04729172T AT04729172T ATE445393T1 AT E445393 T1 ATE445393 T1 AT E445393T1 AT 04729172 T AT04729172 T AT 04729172T AT 04729172 T AT04729172 T AT 04729172T AT E445393 T1 ATE445393 T1 AT E445393T1
Authority
AT
Austria
Prior art keywords
core
coating
tablet
colored core
colouring agent
Prior art date
Application number
AT04729172T
Other languages
English (en)
Inventor
Guy Vergnault
Pascal Grenier
Christophe Dragan
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Application granted granted Critical
Publication of ATE445393T1 publication Critical patent/ATE445393T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
AT04729172T 2003-04-24 2004-04-23 Tablette mit gefärbtem kern ATE445393T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309343 2003-04-24
PCT/IB2004/001702 WO2004093850A1 (en) 2003-04-24 2004-04-23 Tablet with coloured core

Publications (1)

Publication Number Publication Date
ATE445393T1 true ATE445393T1 (de) 2009-10-15

Family

ID=33306520

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04729172T ATE445393T1 (de) 2003-04-24 2004-04-23 Tablette mit gefärbtem kern

Country Status (9)

Country Link
US (1) US20070148229A1 (de)
EP (1) EP1615626B1 (de)
JP (1) JP4908200B2 (de)
AT (1) ATE445393T1 (de)
CY (1) CY1109726T1 (de)
DE (1) DE602004023597D1 (de)
DK (1) DK1615626T3 (de)
ES (1) ES2335008T3 (de)
WO (1) WO2004093850A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4790597B2 (ja) 2003-04-24 2011-10-12 ヤゴテック アーゲー 規定されたコア幾何学的配置を有する遅延放出錠
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
EP1807058A1 (de) * 2004-09-10 2007-07-18 Nitec Pharma Ag Tabletten mit zeitlich kontrollierter gastrointestinaler freisetzung eines wirkstoffes
EP2049123B2 (de) 2006-08-03 2016-08-24 Horizon Pharma AG Behandlung von rheumatoiden erkrankungen mit einem glucocorticoid mit verzögerter freisetzung
EP2391369A1 (de) * 2009-01-26 2011-12-07 Nitec Pharma AG Glukokortikoid-behandlung von asthma mit verzögerter freisetzung
NZ582836A (en) * 2009-01-30 2011-06-30 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
PL2851075T3 (pl) * 2012-05-14 2022-02-21 Shionogi & Co., Ltd. Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874586A (en) 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
GB860708A (en) * 1958-06-23 1961-02-08 Sterling Drug Inc Medicinal tablets comprising 4-aminoquinoline-type drugs and salicylates
US3048526A (en) 1958-08-04 1962-08-07 Wander Company Medicinal tablet
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
US3125491A (en) * 1962-04-06 1964-03-17 Chew able hematinic vitamin tablet
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5047246A (en) 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
DE3930770A1 (de) * 1989-09-14 1991-03-28 Wolfgang F Dr Schoener Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff
US5310578A (en) * 1990-09-17 1994-05-10 Merck Patent Gesellschaft Deposition of cosmetically functional material onto pigments and fillers
DE4100920A1 (de) * 1991-01-15 1992-07-16 Degussa Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
JPH0672861A (ja) * 1992-07-09 1994-03-15 Takeda Chem Ind Ltd 着色固形製剤
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
WO1994008589A1 (en) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
TW272942B (de) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
JPH06256171A (ja) * 1993-03-04 1994-09-13 Shin Etsu Chem Co Ltd セルロース系腸溶性コーチング剤
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
US5709880A (en) * 1995-07-10 1998-01-20 Buckman Laboratories International, Inc. Method of making tabletized ionene polymers
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US5792476A (en) * 1996-12-19 1998-08-11 Abigo Medical Ab Sustained release glucocorticoid pharmaceutical composition
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
GB9905898D0 (en) * 1999-03-15 1999-05-05 Darwin Discovery Ltd Controlled-dose formulation
JP2001017121A (ja) * 1999-07-05 2001-01-23 Anpureenu Europe:Kk 被覆粒体及びその製造方法
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US6720327B2 (en) * 2000-09-27 2004-04-13 Pharmacia Corporation Lactone integrin antagonists
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
JP2002212104A (ja) * 2000-11-17 2002-07-31 Takeda Chem Ind Ltd タルク／硫酸バリウム含有製剤
IL157634A0 (en) * 2001-03-13 2004-03-28 Penwest Pharmaceuticals Co Chronotherapeutic dosage forms containing glucocorticosteroid
EP1245227A1 (de) * 2001-03-31 2002-10-02 Jagotec Ag Pharmazeutische, im Magen aufschwimmende Tablette für die programmierte Freisetzung des Wirkstoffes und Verfahren zur Herstellung des in der Tablette enthaltenen schwimmfähigen Materials
IN191028B (de) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
CA2461653A1 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Edible composition and dosage form comprising an edible shell
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
JP4790597B2 (ja) * 2003-04-24 2011-10-12 ヤゴテック アーゲー 規定されたコア幾何学的配置を有する遅延放出錠
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
US20070148229A1 (en) 2007-06-28
EP1615626B1 (de) 2009-10-14
EP1615626A1 (de) 2006-01-18
CY1109726T1 (el) 2014-09-10
DE602004023597D1 (de) 2009-11-26
JP2006524230A (ja) 2006-10-26
WO2004093850A1 (en) 2004-11-04
ES2335008T3 (es) 2010-03-18
DK1615626T3 (da) 2010-02-08
JP4908200B2 (ja) 2012-04-04

Similar Documents

Publication Publication Date Title
CY1109726T1 (el) Δισκιο εγχρωμου πυρηνα
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
ATE286715T1 (de) Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
AR021391A1 (es) Inhaladores presurizados de dosis medidas (mdi) y su uso.
AR064901A2 (es) Una pelicula consumible adaptada para disolverse en la boca de un consumidor
ES2125380T3 (es) Dispositivo medico para la administracion de ingredientes activos o medicamentos a dosis muy bajas, en especial medicamentos homeopaticos.
ES2084390T3 (es) Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen.
AR032912A1 (es) Formulacion farmaceutica
ES2196620T3 (es) Formulacion de liberacion prolongada que contiene venlafaxina.
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
NO20011217D0 (no) Doseringsform omfattende væskeformulering
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
PT994887E (pt) Glicosidos modificados composicoes que compreendem os mesmos e metodos para a sua utilizacao
PL1615628T3 (pl) Plaster medyczny z substancją czynną o zmniejszonej widoczności na skórze
BR0104283A (pt) Agente de barreira para um artigo absorvente, e, artigo absorvente
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
AR020205A1 (es) Formulacion efervescente esterilizante.
DE602004009060D1 (de) Kissen zur hautreinigung und hautbefeuchtung
CH691791A8 (de) Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung.
PT1200071E (pt) Comprimidos fracamente doseados e processo de preparacao

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties